You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 5, 2024

Investigational Drug Information for ampreloxetine


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for ampreloxetine?

ampreloxetine is an investigational drug.

There have been 6 clinical trials for ampreloxetine. The most recent clinical trial was a Phase 3 trial, which was initiated on February 22nd 2019.

The most common disease conditions in clinical trials are Hypotension, Orthostatic, Hypotension, and Pure Autonomic Failure. The leading clinical trial sponsors are Theravance Biopharma and [disabled in preview].

There are eighteen US patents protecting this investigational drug and one hundred and eighteen international patents.

Recent Clinical Trials for ampreloxetine
TitleSponsorPhase
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System AtrophyTheravance BiopharmaPhase 3
Thorough QT Study to Evaluate Ampreloxetine in Healthy SubjectsTheravance BiopharmaPhase 1
Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of TD-9855Theravance BiopharmaPhase 1

See all ampreloxetine clinical trials

Clinical Trial Summary for ampreloxetine

Top disease conditions for ampreloxetine
Top clinical trial sponsors for ampreloxetine

See all ampreloxetine clinical trials

US Patents for ampreloxetine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
ampreloxetine ⤷  Sign Up 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) ⤷  Sign Up
ampreloxetine ⤷  Sign Up 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) ⤷  Sign Up
ampreloxetine ⤷  Sign Up Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) ⤷  Sign Up
ampreloxetine ⤷  Sign Up Methods for treating neurogenic orthostatic hypotension THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) ⤷  Sign Up
ampreloxetine ⤷  Sign Up 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) ⤷  Sign Up
ampreloxetine ⤷  Sign Up Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound Theravance Biopharma R&D IP, LLC (South San Francisco, CA) ⤷  Sign Up
ampreloxetine ⤷  Sign Up Process for preparing 2-(1-(tert-butoxycarbonyl)piperidine-4-yl)benzoic acid THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for ampreloxetine

Drugname Country Document Number Estimated Expiration Related US Patent
ampreloxetine Argentina AR074128 2028-11-14 ⤷  Sign Up
ampreloxetine Argentina AR074350 2028-11-14 ⤷  Sign Up
ampreloxetine Argentina AR114965 2028-11-14 ⤷  Sign Up
ampreloxetine Australia AU2009313948 2028-11-14 ⤷  Sign Up
ampreloxetine Australia AU2009313949 2028-11-14 ⤷  Sign Up
ampreloxetine Australia AU2009313951 2028-11-14 ⤷  Sign Up
ampreloxetine Brazil BRPI0921593 2028-11-14 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.